Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing NaN - NaN of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

Not yet recruiting
  • Myeloid Malignancy
  • +4 more
  • Telehealth Serious Illness Care Program
  • Education Control
  • Rochester, New York
    University of Rochester
May 24, 2023

Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Rochester, Minnesota
  • +1 more
Feb 15, 2023

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Nov 2, 2022

MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

Completed
Has Results
  • Myelodysplastic Syndromes
  • +2 more
  • Birmingham, Alabama
  • +58 more
Aug 24, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Acute Myeloid Leukemia, MDS Trial in Rochester (Inpatient serious illness care program)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Inpatient serious illness care program
  • Rochester, New York
    University of Rochester
Jun 21, 2022

MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

Active, not recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Neoplasm
  • Azacitidine Subcutaneous Injection or Intravenous Infusion
  • +2 more
  • Miami, Florida
  • +4 more
Jun 20, 2022

Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)

Recruiting
  • Acute Leukemia
  • +9 more
  • Total Body Irradiation 1200 cGy
  • +7 more
  • Rochester, New York
    Wilmot Cancer Institute
Jun 20, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

MDS Trial in United States (Pracinostat, Azacitidine)

Terminated
Has Results
  • Myelodysplastic Syndromes
  • Duarte, California
  • +24 more
Feb 4, 2022

A Telehealth Advance Care Planning Intervention for Older Acute

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Telehealth
  • Rochester, New York
    University of Rochester
Jan 3, 2022

MDS Trial in France, Germany, United States (Oral rigosertib)

Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
Jun 15, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    MDS Trial in Canada, United States (anti-thymocyte globulin)

    Completed
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • Washington, District of Columbia
    • +27 more
    Jan 24, 2021

    MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • rigosertib sodium
    • Stanford, California
    • +34 more
    Jun 29, 2020

    MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    Jun 29, 2020

    MDS Trial in Germany, United States (lenalidomide)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Scottsdale, Arizona
    • +31 more
    Nov 6, 2019

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • +4 more
    • therapeutic allogeneic lymphocytes
    • +6 more
    • Denver, Colorado
    • +13 more
    Sep 13, 2019

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (baclofen/amitriptyline/ketamine gel, )

    Completed
    Has Results
    • Chronic Myeloproliferative Disorders
    • +9 more
    • baclofen/amitriptyline/ketamine gel
    • placebo
    • Scottsdale, Arizona
    • +164 more
    Jul 25, 2017

    Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in United States (American ginseng, )

    Completed
    Has Results
    • Chronic Myeloproliferative Disorders
    • +9 more
    • American ginseng
    • placebo
    • Scottsdale, Arizona
    • +325 more
    Dec 19, 2016

    Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Rochester (biological, drug, procedure, radiation)

    Terminated
    Has Results
    • Chronic Myeloproliferative Disorders
    • +6 more
    • graft-versus-tumor induction therapy
    • +6 more
    • Rochester, New York
      James P. Wilmot Cancer Center at University of Rochester Medical
    Sep 28, 2016

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (ondansetron, )

    Completed
    • Chronic Myeloproliferative Disorders
    • +9 more
    • Scottsdale, Arizona
    • +11 more
    Jul 1, 2016

    MDS Trial in Rochester (bortezomib)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Rochester, New York
      James P. Wilmot Cancer Center at University of Rochester Medical
    Apr 4, 2016